Korean J Pain.  2021 Jun;34(3):332-338. 10.3344/kjp.2021.34.3.332.

Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Wonkwang University Hospital, Wonkwang University School of Medicine, Iksan, Korea
  • 2Department of Anatomy, Wonkwang University School of Medicine, Iksan, Korea
  • 3Jesaeng-Euise Clinical Anatomy Center, Wonkwang University School of Medicine, Iksan, Korea
  • 4Department of Nursing, Kunsan National University, Gunsan, Korea

Abstract

Background
Trigeminal neuralgia (TN) is one of the most painful disorder in the orofacial region, and many patients have suffered from this disease. For the effective management of TN, fundamental epidemiologic data related to the target population group are essential. Thus, this study was performed to clarify the epidemiological characteristics of TN in the Korean population. This is the first national study to investigate the prevalence of TN in Korean patients.
Methods
From 2014 to 2018, population-based medical data for 51,276,314 subscribers to the National Health Insurance Service of Korea were used for this study.
Results
The incidence of TN was 100.21 per 100,000 person-years in the year of 2018 in Korea, and the male to female ratio was 1:2.14. The age group of 51-59 years had the highest prevalence of TN. Constant increases in medical cost, regional imbalance, and differences in prescription patterns by the medical specialties were showed in the management of TN.
Conclusions
The results in this study will not only help to study the characteristics of TN, but also serve as an important basis for the effective management of TN in Korea.

Keyword

Big Data; Cohort Studies; Epidemiologic Studies; Facial Pain; Incidence; National Health Programs; Patient Acceptance of Health Care; Population Surveillance; Prevalence; Republic of Korea; Trigeminal Neuralgia

Figure

  • Fig. 1 Incidence of trigeminal neuralgia in Korea between 2014 and 2018.

  • Fig. 2 Distribution of trigeminal neuralgia by age and sex groups in 2018.

  • Fig. 3 Regional distribution of trigeminal neuralgia in 2018.

  • Fig. 4 Medical specialty related to the management of trigeminal neuralgia in 2018.

  • Fig. 5 Healthcare resource utilization for trigeminal neuralgia in 2018.

  • Fig. 6 Trend of medical cost for the management of trigeminal neuralgia between 2014 and 2018.

  • Fig. 7 Medical cost by the medical specialties in 2018.

  • Fig. 8 Prescription patterns for trigeminal neuralgia by medical specialty in 2018. NSAIDs: nonsteroidal anti-inflammatory drugs.


Cited by  1 articles

New insight into the mandibular nerve at the foramen ovale level for percutaneous radiofrequency thermocoagulation
Peng-Bo Zhu, sub, sub, Yeon-Dong Kim, sub, sub, Ha Yeong Jeong, Miyoung Yang, Hyung-Sun Won
Korean J Pain. 2023;36(4):465-472.    doi: 10.3344/kjp.23186.


Reference

1. Headache Classification Committee of the International Headache Society (IHS). 2018; The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38:1–211. DOI: 10.1177/0333102417738202. PMID: 29368949.
2. Love S, Coakham HB. 2001; Trigeminal neuralgia: pathology and pathogenesis. Brain. 124(Pt 12):2347–60. DOI: 10.1093/brain/124.12.2347. PMID: 11701590.
Article
3. Adams CB. 1989; Microvascular compression: an alternative view and hypothesis. J Neurosurg. 70:1–12. DOI: 10.3171/jns.1989.70.1.0001. PMID: 2642544.
Article
4. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. 2000; The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 123(Pt 4):665–76. DOI: 10.1093/brain/123.4.665. PMID: 10733998.
Article
5. Tölle T, Dukes E, Sadosky A. 2006; Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 6:153–60. DOI: 10.1111/j.1533-2500.2006.00079.x. PMID: 17147591.
Article
6. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. 2008; Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 71:1183–90. DOI: 10.1212/01.wnl.0000326598.83183.04. PMID: 18716236.
Article
7. Marbach JJ, Lund P. 1981; Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes. Pain. 11:73–84. DOI: 10.1016/0304-3959(81)90140-8. PMID: 7301402.
Article
8. Han SH, Lee KH, Kim ME, Kim KS. 2009; Treatment pattern of patients with neuropathic pain in Korea. J Oral Med Pain. 34:197–205.
9. Holland M, Noeller J, Buatti J, He W, Shivapour ET, Hitchon PW. 2015; The cost-effectiveness of surgery for trigeminal neuralgia in surgically naïve patients: a retrospective study. Clin Neurol Neurosurg. 137:34–7. DOI: 10.1016/j.clineuro.2015.06.011. PMID: 26123528.
Article
10. El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Abdel Hakeem M N, Badry R, et al. 2013; Prevalence of trigeminal neuralgia in Al-Quseir city (Red sea Governorate), Egypt. Clin Neurol Neurosurg. 115:1792–4. DOI: 10.1016/j.clineuro.2013.04.014. PMID: 23692870.
Article
11. Mueller D, Obermann M, Yoon MS, Poitz F, Hansen N, Slomke MA, et al. 2011; Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 31:1542–8. DOI: 10.1177/0333102411424619. PMID: 21960648.
Article
12. Lee YS, Kim NH, Sohn HS, Choi KE, Shin HT. 2010; Development of drug utilization review guidelines for therapeutic duplication of antipyretics, analgesics, and anti-inflammatory drugs registered in Korea. Korean J Clin Pharm. 20:213–20. DOI: 10.1111/j.1365-2125.2010.03688.x. PMID: 20653674. PMCID: PMC2911551.
13. De Toledo IP, Conti Réus J, Fernandes M, Porporatti AL, Peres MA, Takaschima A, et al. 2016; Prevalence of trigeminal neuralgia: a systematic review. J Am Dent Assoc. 147:570–6.e2. DOI: 10.1016/j.adaj.2016.02.014. PMID: 27017183.
14. Katusic S, Beard CM, Bergstralh E, Kurland LT. 1990; Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 27:89–95. DOI: 10.1002/ana.410270114. PMID: 2301931.
Article
15. Hall GC, Carroll D, Parry D, McQuay HJ. 2006; Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 122:156–62. DOI: 10.1016/j.pain.2006.01.030. PMID: 16545908.
Article
16. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. 2009; Incidence of facial pain in the general population. Pain. 147:122–7. DOI: 10.1016/j.pain.2009.08.023. PMID: 19783099.
Article
17. Bangash TH. 2011; Trigeminal neuralgia: frequency of occurrence in different nerve branches. Anesth Pain Med. 1:70–2. DOI: 10.5812/aapm.2164. PMID: 25729659. PMCID: PMC4335746.
Article
18. Rozen TD. 2004; Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol Clin. 22:185–206. DOI: 10.1016/S0733-8619(03)00094-X. PMID: 24703544.
19. Girard-Tremblay L, Auclair V, Daigle K, Léonard G, Whittingstall K, Goffaux P. 2014; Sex differences in the neural representation of pain unpleasantness. J Pain. 15:867–77. DOI: 10.1016/j.jpain.2014.05.004. PMID: 24887007.
Article
20. Cui W, Yu X, Zhang H. 2014; The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in idiopathic trigeminal neuralgia patients. J Headache Pain. 15:42. DOI: 10.1186/1129-2377-15-42. PMID: 24950698. PMCID: PMC4080683.
Article
21. Bang S, Kim YS, Lee S, Park U, Kim TK, Choi Y. 2020; Prevalence of common causes of neuropathic pain in Korea: population-based observational study. J Int Med Res. 48:300060519888102. DOI: 10.1177/0300060519888102. PMID: 31775560. PMCID: PMC7516997.
Article
22. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. 2008; AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 15:1013–28. DOI: 10.1111/j.1468-1331.2008.02185.x. PMID: 18721143.
Article
23. Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. 2017; Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 37:648–57. DOI: 10.1177/0333102416687280. PMID: 28076964.
Article
24. Di Stefano G, La Cesa S, Truini A, Cruccu G. 2014; Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 15:34. DOI: 10.1186/1129-2377-15-34. PMID: 24912658. PMCID: PMC4067104.
Article
25. Feller L, Khammissa RAG, Fourie J, Bouckaert M, Lemmer J. 2017; Postherpetic neuralgia and trigeminal neuralgia. Pain Res Treat. 2017:1681765. DOI: 10.1155/2017/1681765. PMID: 29359044. PMCID: PMC5735631.
Article
26. Moore RA, Chi CC, Wiffen PJ, Derry S, Rice AS. 2015; Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev. 2015:CD010902. DOI: 10.1002/14651858.CD010902.pub2. PMID: 26436601. PMCID: PMC6481590.
Article
27. Galluzzi KE. 2005; Management of neuropathic pain. J Am Osteopath Assoc. 105(9 Suppl 4):S12–9. PMID: 16273720.
28. Dowell D, Haegerich TM, Chou R. 2016; CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 315:1624–45. DOI: 10.1001/jama.2016.1464. PMID: 26977696. PMCID: PMC6390846.
Article
29. Fornasari D. 2017; Pharmacotherapy for neuropathic pain: a review. Pain Ther. 6(Suppl 1):25–33. DOI: 10.1007/s40122-017-0091-4. PMID: 29178034. PMCID: PMC5701897.
Article
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr